angiotensin ii has been researched along with Hypersensitivity, Type III in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Egido, J; Gómez-Guerrero, C; Hernández-Vargas, P; López-Franco, O; Okumura, K; Ra, C; Ruiz-Ortega, M; Sanjuán, G; Shirato, I; Sugaya, T; Suzuki, Y; Tomino, Y | 1 |
Blanco, J; Egido, J; Esteban, V; Lorenzo, O; Mezzano, S; Ruiz-Ortega, M; Ruperez, M | 1 |
Egido, J; Esteban, V; Lorenzo, O; Mezzano, S; Plaza, JJ; Ruiz-Ortega, M; Rupérez, M | 1 |
Bustos, C; Egido, J; Hernández-Presa, MA; Lorenzo, O; Plaza, JJ; Ruiz-Ortega, M | 1 |
4 other study(ies) available for angiotensin ii and Hypersensitivity, Type III
Article | Year |
---|---|
Susceptibility to T cell-mediated injury in immune complex disease is linked to local activation of renin-angiotensin system: the role of NF-AT pathway.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Glomerular Basement Membrane Disease; Bone Marrow Cells; Calcineurin; CD4-Positive T-Lymphocytes; Cell Movement; Chemokines; Chemotaxis, Leukocyte; DNA-Binding Proteins; Female; Genetic Predisposition to Disease; Glomerular Mesangium; Glomerulonephritis; Hypersensitivity, Delayed; Immune Complex Diseases; Kidney Glomerulus; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; NFATC Transcription Factors; Nuclear Proteins; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, IgG; Renin-Angiotensin System; RNA, Messenger; Signal Transduction; Skin Tests; T-Lymphocyte Subsets; Th1 Cells; Transcription Factors | 2002 |
Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cells, Cultured; Chemokines; Cytokines; Disease Models, Animal; Female; Immune Complex Diseases; Inflammation Mediators; Infusion Pumps; Infusions, Parenteral; Kidney; Mesangial Cells; Nephritis; Quinapril; Rats; Rats, Wistar; RNA, Messenger; Tetrahydroisoquinolines; Tumor Necrosis Factor-alpha; Up-Regulation | 2002 |
Angiotensin II increases connective tissue growth factor in the kidney.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Cells, Cultured; Connective Tissue Growth Factor; Female; Immediate-Early Proteins; Immune Complex Diseases; Immunohistochemistry; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Kidney; Nephritis; Quinapril; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydroisoquinolines; Up-Regulation; Vasoconstrictor Agents | 2003 |
Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis.
Topics: Administration, Oral; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Movement; Cells, Cultured; Chemokine CCL2; Down-Regulation; Glomerular Mesangium; Glomerulonephritis; Immune Complex Diseases; Isoquinolines; Kidney Glomerulus; Leukocytes, Mononuclear; NF-kappa B; Quinapril; Rats; Rats, Wistar; RNA, Messenger; Tetrahydroisoquinolines; Up-Regulation | 1998 |